カテゴリ： GlobalData, アメリカ, 企業調査

NuVasive Inc (NUVA)：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：NuVasive Inc (NUVA) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C7267
◆発行会社（調査会社）：GlobalData
◆発行日：2018年10月
◆ページ数：64
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
NuVasive Inc (NuVasive) is a medical device company that provides minimally invasive, procedurally-integrated spine solutions. The company principally provides Maximum Access Surgery (MAS), a minimally-disruptive surgical platform. MAS platform enables surgeons to perform a range of minimally-disruptive spine procedures in all regions of the spine and from various surgical approaches. MAS platform combines three product categories, namely, MaXcess retractors, its specialized implants and fixation products and its nerve monitoring systems and service offerings. The company’s products find application in spine fusion surgery, including biologics used to aid in the spinal fusion process. NuVasive is headquartered in San Diego, California, the US.

NuVasive Inc (NUVA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
NuVasive Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
NuVasive Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
NuVasive Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
NuVasive Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
NuVasive Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
NuVasive Inc, Medical Equipment, Deal Details 11
Venture Financing 11
Vertera Raises USD3.1 Million in Venture Financing 11
Partnerships 12
NuVasive Enters into Licensing Agreement with Biedermann Technologies 12
Equity Offering 13
Ellipse Technologies Withdraws IPO for up to USD75 Million 13
Debt Offering 14
NuVasive Raises USD650 Million in Private Placement of 2.25% Notes Due 2021 14
Acquisition 16
NuVasive to Acquire SafePassage 16
NuVasive Acquires Vertera Spine 17
NuVasive Acquires Biotronic NeuroNetwork for USD98 Million 18
NuVasive to Acquire Mega Surgical 19
NuVasive Acquires Ellipse Technologies 20
Biotronic NeuroNetwork Acquires Neurophysiology Associates, Provider Of Intraoperative Monitoring Services 21
NuVasive Acquires ANC, Maker Of Spine Implant, For US$4.5 Million 22
NuVasive Inc – Key Competitors 23
NuVasive Inc – Key Employees 24
NuVasive Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 28
Strategy And Business Planning 28
Aug 29, 2017: NuVasive Announces World-Class Innovation Center At San Diego Headquarters 28
Financial Announcements 29
Jul 31, 2018: NuVasive announces second quarter 2018 financial results 29
May 01, 2018: Nuvasive Announces First Quarter 2018 Financial Results 30
Feb 26, 2018: NuVasive Announces Fourth Quarter and Full Year 2017 Financial Results 31
Jan 08, 2018: NuVasive Announces Preliminary Unaudited Full Year 2017 Revenue Results And Preliminary 2018 Outlook 32
Oct 24, 2017: NuVasive Reports Third Quarter 2017 Financial Results 33
Jul 27, 2017: NuVasive Reports Second Quarter 2017 Financial Results 34
Apr 25, 2017: NuVasive Announces First Quarter 2017 Financial Results 35
Feb 09, 2017: NuVasive Reports Fourth Quarter And Full Year 2016 Financial Results 36
Jan 09, 2017: NuVasive Announces Select Preliminary Unaudited Full Year 2016 Financial Results and 2017 Outlook 38
Corporate Communications 39
Sep 21, 2018: Scott Huennekens To Join NuVasive Board Of Directors 39
Aug 16, 2018: NuVasive appoints Dale Wolf to lead Ohio manufacturing facility 41
Jun 11, 2018: NuVasive Announces New Finance Team 42
Feb 08, 2018: John DeFord To Join NuVasive Board Of Directors 43
Dec 14, 2017: NuVasive Appoints Experienced Spine Executive Michael Piccirillo To Lead New Global Surgeon Education Platform 44
Aug 15, 2017: NuVasive Appoints Rajesh J. Asarpota As Chief Financial Officer 45
Jul 27, 2017: NuVasive Announces New Organizational Structure To Drive Growth And Profitability Goals 46
Jun 01, 2017: NuVasive Appoints Skip Kiil As Executive Vice President, International 47
Product News 48
Oct 04, 2018: NuVasive to showcase comprehensive solutions for complex spinal deformities at Scoliosis Research Society Annual Meeting 48
Sep 04, 2018: NuVasive to feature Lateral Single-Position Surgery and Surgical Intelligence at SMISS annual forum 49
May 16, 2018: NuVasive Sponsors SOLAS 2018, Hosts Workshop On Latest Lateral Innovations 50
Apr 24, 2018: NuVasive Sponsors AANS 2018, Hosts Workshops And Presentations On Latest Innovations 51
Apr 02, 2018: NuVasive Portfolio Now Includes ALIF Retractor Platform For Lateral And Supine Approaches 52
Oct 25, 2017: NuVasive Unveils Latest Innovation At NASS 2017 53
Jul 10, 2017: NuVasive Leading Sponsor Of IMAST 2017 And Hosting Workshops Featuring Advanced Technologies 54
Jun 05, 2017: NuVasive Magnetic, Non-Invasive Platforms Featured In The Journal Of Orthopaedic Trauma Supplement 55
May 02, 2017: NuVasive Announces Sponsorship Of EPOSNA 2017 And Launches New Monthly Pediatric Spinal Deformity Podcast 56
Mar 20, 2017: New Evidence-Based Recommendation Released From NICE (U.K.) For Lateral Interbody Fusion 57
Other Significant Developments 58
Oct 08, 2018: NuVasive clinical services awarded sole source Intraoperative Neuromonitoring Services contract with Premier 58
May 23, 2018: NuVasive SpineTRACK Registry Reaches Significant Enrollment Milestone Of 10,000 Patients 59
Dec 21, 2017: NuVasive Comments On Expected Impact Of U.S. Tax Reform 60
Oct 23, 2017: NuVasive Extends Its Leadership As Lateral Spine Technology Innovator With New Lateral Single-Position Surgery Procedure 61
May 22, 2017: NuVasive Announces Educational Initiatives In Support Of Spine’s Fastest Growing Spinal Deformity Portfolio 63
Appendix 64
Methodology 64
About GlobalData 64
Contact Us 64
Disclaimer 64

List of Tables
NuVasive Inc, Medical Equipment, Key Facts, 2017 2
NuVasive Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
NuVasive Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
NuVasive Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
NuVasive Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
NuVasive Inc, Deals By Market, 2012 to YTD 2018 9
NuVasive Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Vertera Raises USD3.1 Million in Venture Financing 11
NuVasive Enters into Licensing Agreement with Biedermann Technologies 12
Ellipse Technologies Withdraws IPO for up to USD75 Million 13
NuVasive Raises USD650 Million in Private Placement of 2.25% Notes Due 2021 14
NuVasive to Acquire SafePassage 16
NuVasive Acquires Vertera Spine 17
NuVasive Acquires Biotronic NeuroNetwork for USD98 Million 18
NuVasive to Acquire Mega Surgical 19
NuVasive Acquires Ellipse Technologies 20
Biotronic NeuroNetwork Acquires Neurophysiology Associates, Provider Of Intraoperative Monitoring Services 21
NuVasive Acquires ANC, Maker Of Spine Implant, For US$4.5 Million 22
NuVasive Inc, Key Competitors 23
NuVasive Inc, Key Employees 24
NuVasive Inc, Other Locations 25
NuVasive Inc, Subsidiaries 25

List of Figures
NuVasive Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
NuVasive Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
NuVasive Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
NuVasive Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
NuVasive Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
NuVasive Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
NuVasive Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
NuVasive Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[NuVasive Inc (NUVA)：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • eFFECTOR Therapeutics Inc-製薬・医療分野：企業M&A・提携分析
    Summary eFFECTOR Therapeutics Inc (Effector) is a biopharmaceutical company that concentrates on new class of oncology drugs-selective translation regulators. The company works on the discovery and development of translation regulators as a new small molecule therapeutics that control gene expressio …
  • Subaru Corp：企業の戦略・SWOT・財務分析
    Subaru Corp - Strategy, SWOT and Corporate Finance Report Summary Subaru Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Sitara Chemical Industries Ltd (SITC)：企業の財務・戦略的SWOT分析
    Sitara Chemical Industries Ltd (SITC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • British American Tobacco Plc (BATS)：企業の財務・戦略的SWOT分析
    British American Tobacco Plc (BATS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Ak Bars Bank：企業の戦略・SWOT・財務分析
    Ak Bars Bank - Strategy, SWOT and Corporate Finance Report Summary Ak Bars Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Metso Corporation：企業の戦略・SWOT・財務情報
    Metso Corporation - Strategy, SWOT and Corporate Finance Report Summary Metso Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • TheraDiag SA (ALTER)：医療機器：M&Aディール及び事業提携情報
    Summary Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA, is a biotechnology company that develops, manufactures, and markets vitro diagnostic products. The company offers product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels f …
  • Sensient Technologies Corp (SXT)：企業の財務・戦略的SWOT分析
    Sensient Technologies Corp (SXT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Atomenergoprom：企業の戦略的SWOT分析
    Atomenergoprom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • SimCorp AS (SIM)：企業の財務・戦略的SWOT分析
    SimCorp AS (SIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Eurofins Scientific SE：企業のM&A・事業提携・投資動向
    Eurofins Scientific SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eurofins Scientific SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Commonwealth Scientific and Industrial Research Organisation-医療機器分野：企業M&A・提携分析
    Summary Commonwealth Scientific and Industrial Research Organisation (CSIRO) is a national science agency that conducts research in climate adaptation, bio-security, renewable and energy, farming and food production, and information technology, and mining and manufacturing services, and others. The …
  • Canaan Partners：企業のM&A・事業提携・投資動向
    Canaan Partners - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Canaan Partners Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • CTCI Corporation (9933)-エネルギー分野：企業M&A・提携分析
    Summary CTCI Corporation (CTCI) is an engineering, procurement, and construction services provider that operates along with its subsidiaries and affiliates. It offers construction services includes feasibility study, design, and fabrication; project related services: project management, supervision, …
  • Korea Electric Power Corp：企業の発電所・SWOT分析2018
    Korea Electric Power Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Daiwa Can Co., Ltd.：企業の戦略・SWOT・財務情報
    Daiwa Can Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daiwa Can Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Lycatel Services Ltd：企業の戦略的SWOT分析
    Lycatel Services Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Cost Plus Inc：企業の戦略的SWOT分析
    Cost Plus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • IndiPharm Inc-製薬・医療分野：企業M&A・提携分析
    Summary IndiPharm Inc (IndiPharm) is a clinical research organization that provides drug safety services to support clinical research and marketed products. The organization offers CRO services such as preparing and filing regulatory submissions, obtaining required import and export licenses, protoc …
  • Visa Inc：企業の戦略・SWOT・財務情報
    Visa Inc - Strategy, SWOT and Corporate Finance Report Summary Visa Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆